Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Researchers are seeking participants for a study to identify accurate biological indicators of ALS onset, progression and response to treatment
Posted on Wednesday, January 18, 2012 - 15:52, By: Amy Madsen
The Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) is actively seeking participants for a study designed to identify and validate biomarkers in amyotrophic lateral sclerosis (ALS).
Posted on Thursday, September 1, 2011 - 10:50, By: Amy Madsen
In its latest round of funding this July, MDA awarded nine grants totaling more than $2.5 million to research projects focused on uncovering the causes of, and developing therapies for, amyotrophic lateral sclerosis (ALS).
The new grants were awarded to investigators at labs in the United States...
Posted on Saturday, January 1, 2011 - 14:18, By: Amy Madsen
A biomarker is any biological indicator that doctors or researchers can objectively measure and evaluate to determine an individual’s health.
Examples of common biomarkers include body temperature and heart rate, a mutated gene or brain and spinal cord images obtained through imaging techniques...
Posted on Thursday, April 1, 2004 - 07:00, By: Margaret Wahl
VEGF deficiency implicated in second disease
A recent MDA-supported study found that a deficiency of a protein called vascular endothelial growth factor (VEGF) is likely to be a major contributor to spinal-bulbar muscular atrophy (SBMA, or...